Flora Growth (FLGC) Revenue & Revenue Breakdown
Flora Growth Revenue Highlights
Latest Revenue (Y)
$76.07M
Latest Revenue (Q)
$15.68M
Main Segment (Y)
Pharmaceuticals and Nutraceuticals
Main Geography (Y)
GERMANY
Flora Growth Revenue by Period
Flora Growth Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $76.07M | 104.65% |
2022-12-31 | $37.17M | 313.93% |
2021-12-31 | $8.98M | 8371.70% |
2020-12-31 | $106.00K | 100.00% |
2019-12-31 | - | - |
Flora Growth Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $15.68M | -13.02% |
2024-03-31 | $18.03M | 0.31% |
2023-12-31 | $17.98M | 3.80% |
2023-09-30 | $17.32M | -19.31% |
2023-06-30 | $21.46M | 6.73% |
2023-03-31 | $20.11M | 75.01% |
2022-12-31 | $11.49M | 6.73% |
2022-09-30 | $10.77M | 7.96% |
2022-06-30 | $9.97M | 101.60% |
2022-03-31 | $4.95M | 3.71% |
2021-12-31 | $4.77M | 127.85% |
2021-09-30 | $2.09M | 80.59% |
2021-06-30 | $1.16M | 9.44% |
2021-03-31 | $1.06M | 1898.11% |
2020-12-31 | $53.00K | - |
2020-09-30 | $53.00K | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-06-30 | - | - |
Flora Growth Revenue Breakdown
Flora Growth Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 21 |
---|---|
Pharmaceuticals and Nutraceuticals | $2.34M |
Flora Growth Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 21 |
---|---|---|
UNITED STATES | $36.54M | - |
GERMANY | $38.26M | - |
United States | - | $1.68M |
Pharmaceuticals and Nutraceuticals | - | $2.34M |
Canada | - | $380.00K |
Quarterly Revenue by Country
Country | Mar 24 | Dec 23 | Jun 23 |
---|---|---|---|
GERMANY | $11.34M | $27.46M | $10.80M |
UNITED STATES | $6.52M | $26.18M | $10.35M |
Flora Growth Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
INCR | InterCure | $355.55M | $73.47M |
FLGC | Flora Growth | $76.07M | $15.68M |
SBFM | Sunshine Biopharma | $39.85M | $9.30M |
TKNO | Alpha Teknova | $36.68M | $9.61M |
CLVR | Clever Leaves | $17.42M | $4.64M |
SNOA | Sonoma Pharmaceuticals | $12.73M | $3.44M |
GHSI | Guardion Health Sciences | $12.25M | $36.35K |
PRFX | PainReform | - | - |
FLGC Revenue FAQ
What is Flora Growth’s yearly revenue?
Flora Growth's yearly revenue for 2023 was $76.07M, representing an increase of 104.65% compared to 2022. The company's yearly revenue for 2022 was $37.17M, representing an increase of 313.93% compared to 2021. FLGC's yearly revenue for 2021 was $8.98M, representing an increase of 8371.70% compared to 2020.
What is Flora Growth’s quarterly revenue?
Flora Growth's quarterly revenue for Q2 2024 was $15.68M, a -13.02% decrease from the previous quarter (Q1 2024), and a -26.92% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.03M, a 0.31% increase from the previous quarter (Q4 2023), and a -10.32% decrease year-over-year (Q1 2023). FLGC's quarterly revenue for Q4 2023 was $17.98M, a 3.80% increase from the previous quarter (Q3 2023), and a 56.45% increase year-over-year (Q4 2022).
What is Flora Growth’s revenue growth rate?
Flora Growth's revenue growth rate for the last 3 years (2021-2023) was 747.12%, and for the last 5 years (2019-2023) was 0%.
What are Flora Growth’s revenue streams?
Flora Growth's revenue streams in c 21 are Pharmaceuticals and Nutraceuticals
What is Flora Growth’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of Flora Growth was Pharmaceuticals and Nutraceuticals. This segment made a revenue of $2.34M, representing 100.00% of the company's total revenue.